• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

Fidaxomicin

CAS No. 873857-62-6

Fidaxomicin ( OPT-80;PAR-101 )

产品货号. M16356 CAS No. 873857-62-6

Fidaxomicin(OPT-80; PAR-101) is anew class of narrow spectrum macrocyclic antibiotic drug.

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥284 有现货
10MG ¥324 有现货
25MG ¥437 有现货
50MG ¥599 有现货
100MG ¥1021 有现货
200MG ¥1507 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    Fidaxomicin
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    Fidaxomicin(OPT-80; PAR-101) is anew class of narrow spectrum macrocyclic antibiotic drug.
  • 产品描述
    Fidaxomicin(OPT-80; PAR-101) is anew class of narrow spectrum macrocyclic antibiotic drug, selective eradication of pathogenic Clostridium difficile with minimal disruption to the multiple species of bacteria.Bacterial Infection Approved
  • 同义词
    OPT-80;PAR-101
  • 通路
    GPCR/G Protein
  • 靶点
    Antibacterial
  • 受体
    RNApolymerase
  • 研究领域
    Infection
  • 适应症
    Bacterial Infection

化学信息

  • CAS Number
    873857-62-6
  • 分子量
    1058.04
  • 分子式
    C52H74Cl2O18
  • 纯度
    >98% (HPLC)
  • 溶解度
    DMSO: ≥ 33 mg/mL
  • SMILES
    O=C(O[C@@H]1[C@@H](C)O[C@@H](OC/C2=C\C=C\C[C@H](O)/C(C)=C/[C@H](CC)[C@@H](O[C@H]3[C@@H](O)[C@@H](O)[C@H](OC(C(C)C)=O)C(C)(C)O3)/C(C)=C/C(C)=C/C[C@@H]([C@H](O)C)OC2=O)[C@@H](OC)[C@H]1O)C4=C(O)C(Cl)=C(O)C(Cl)=C4CC
  • 化学全称
    Oxacyclooctadeca-3,5,9,13,15-pentaen-2-one, 3-[[[6-deoxy-4-O-(3,5-dichloro-2-ethyl-4,6-dihydroxybenzoyl)-2-O-methyl-β-D-mannopyranosyl]oxy]methyl]-12-[[6-deoxy-5-C-methyl-4-O-(2-methyl-1-oxopropyl)-β-D-lyxo-hexopyranosyl]oxy]-11-ethyl-8-hydroxy-18-[(1R)-1

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

产品手册
关联产品
  • Minocycline hydrochl...

    A tetracycline antibiotic with neuroprotective, antiapoptotic, anti-inflammatory and antimicrobial effects.

  • Totarol

    Totarol shows antibacterial effects against several pathogenic Gram-positive bacteria, mycobacterium tuberculosis.

  • FSL 1

    TLR2/6 agonist (also a putative TLR10 ligand). Activates NF-κB. Induces pro-inflammatory cytokines including IL-8, IL-1β, CCL20 and TNF-α in vitro. Synergizes with IFNγ to induce CXCL10 release from melanoma cells.